Bausch Health Companies BHC
NYSE BHC
$8.40 +0.21 (+2.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Bausch Health Companies (BHC) Return on Sales [ROS] (2009 - 2026)

Updated

Bausch Health Companies' Return on Sales [ROS] was 25.95% in Q2 2026, up 8.40 percentage points from 17.55% a year earlier and up 63.59 percentage points from the prior quarter.

Analysis

Bausch Health Companies (BHC) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Bausch Health Companies' Return on Sales [ROS] was 8.14% through Jun 30, 2026, down 8.05 percentage points year-over-year; for FY2025, it was 17.66%, up 1.60 percentage points from FY2024.

  • Return on Sales [ROS] has now increased for four consecutive years, with a five-year change of +9.24 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 16.06% in FY2024 (+5.07 pp), 11.00% in FY2023 (+5.41 pp), 5.59% in FY2022 (+0.25 pp) and 5.34% in FY2021 (-3.09 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q3 2021.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of -2.07 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2023 (a gain of 25.79 percentage points); the worst was Q1 2026 (a drop of 49.86 percentage points).
  • Per Business Quant data, BHC's Return on Sales [ROS] in the three quarters before Q2 2026 was -37.64% (Q1 2026), 16.95% (Q4 2025) and 23.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 24.35%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 36.01%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.89%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 29.12%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 41.71%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 32.98%
10 Bausch Health Companies 3.16 Bn -3.76 Bn 2.21 Bn 33.42%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 33.42%
Jun 30, 2026 25.95%
Mar 31, 2026 -37.64%
Dec 31, 2025 16.95%
Sep 30, 2025 23.09%
Jun 30, 2025 17.55%
Mar 31, 2025 12.22%
Dec 31, 2024 21.81%
Sep 30, 2024 12.67%
Jun 30, 2024 16.19%
Mar 31, 2024 13.05%
Dec 31, 2023 15.03%
Sep 30, 2023 0.63%
Jun 30, 2023 19.01%
Mar 31, 2023 9.00%
Dec 31, 2022 -10.76%
Sep 30, 2022 11.93%
Jun 30, 2022 8.19%
Mar 31, 2022 14.86%
Dec 31, 2021 16.71%
API Access

Bausch Health Companies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BHC&period=max&api_key=YOUR_API_KEY